HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Fang Selected Research

Mimosine

1/2016Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury.
5/2013miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.
1/2012Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Fang Research Topics

Disease

63Neoplasms (Cancer)
04/2022 - 10/2005
41Breast Neoplasms (Breast Cancer)
01/2022 - 08/2013
20Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2010
18Hypoxia (Hypoxemia)
01/2021 - 01/2012
16Inflammation (Inflammations)
08/2022 - 05/2007
16Fibrosis (Cirrhosis)
01/2022 - 12/2010
16Reperfusion Injury
01/2022 - 12/2012
10Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2020
9Triple Negative Breast Neoplasms
04/2022 - 01/2016
9Infections
01/2022 - 10/2012
9Carcinoma (Carcinomatosis)
01/2021 - 10/2005
8Chronic Renal Insufficiency
09/2022 - 01/2012
8Neoplasm Metastasis (Metastasis)
04/2022 - 01/2019
8Body Weight (Weight, Body)
12/2021 - 10/2013
8Ischemia
01/2021 - 09/2013
7Hypertension (High Blood Pressure)
11/2021 - 01/2008
5Type 2 Diabetes Mellitus (MODY)
07/2021 - 02/2014
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 06/2017
5Carcinogenesis
01/2021 - 11/2013
5Heart Failure
01/2021 - 12/2012
4Abscess
01/2021 - 11/2016
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 09/2009
4Hepatocellular Carcinoma (Hepatoma)
10/2019 - 01/2001
3Obesity
12/2021 - 01/2019
3Non-alcoholic Fatty Liver Disease
12/2021 - 01/2018
3Kidney Diseases (Kidney Disease)
01/2021 - 09/2009
3Acute Promyelocytic Leukemia
01/2020 - 04/2012
3Diabetes Mellitus
01/2019 - 02/2014
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 03/2015
3Brain Ischemia (Cerebral Ischemia)
01/2018 - 12/2014
3Infarction (Infarctions)
09/2017 - 03/2015
3Cardiomegaly (Heart Hypertrophy)
07/2015 - 10/2013
3Afibrinogenemia (Fibrinogen Deficiency)
12/2005 - 12/2003
2B-Cell Lymphoma (Lymphoma, B Cell)
08/2022 - 11/2015
2Anemia
06/2022 - 01/2021
2Stroke (Strokes)
01/2022 - 03/2015
2Thrombosis (Thrombus)
01/2022 - 10/2014

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
08/2022 - 12/2003
15Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2008
11Messenger RNA (mRNA)IBA
01/2021 - 09/2007
9Indicators and Reagents (Reagents)IBA
04/2022 - 12/2003
9CytokinesIBA
08/2021 - 08/2013
8Blood Glucose (Blood Sugar)IBA
07/2021 - 01/2012
8RNA (Ribonucleic Acid)IBA
01/2021 - 12/2003
7Pharmaceutical PreparationsIBA
01/2022 - 02/2012
7Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 08/2013
7MicroRNAs (MicroRNA)IBA
01/2020 - 09/2009
6Estrogen ReceptorsIBA
11/2020 - 03/2016
5Immune Checkpoint InhibitorsIBA
01/2022 - 12/2018
5Therapeutic UsesIBA
11/2021 - 01/2008
5Hormones (Hormone)IBA
10/2021 - 01/2020
5Long Noncoding RNAIBA
01/2021 - 01/2019
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 01/2012
5LipopolysaccharidesIBA
01/2020 - 07/2015
4LipidsIBA
12/2021 - 11/2013
4human ERBB2 proteinIBA
10/2021 - 03/2016
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 02/2014
4Phosphotransferases (Kinase)IBA
01/2021 - 12/2014
4Biological ProductsIBA
11/2020 - 08/2014
4Neuroprotective AgentsIBA
01/2018 - 03/2015
3Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 01/2020
3Uric Acid (Urate)IBA
01/2022 - 01/2011
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2014
3aristolochic acid I (aristolochic acid)IBA
01/2022 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2016
3Serum AlbuminIBA
01/2021 - 01/2021
3LigandsIBA
01/2021 - 10/2018
3tyrosine receptor (receptor, tyrosine)IBA
01/2021 - 12/2014
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 12/2014
3GenisteinIBA
01/2020 - 03/2016
3CreatinineIBA
11/2019 - 12/2012
3Oxygen (Dioxygen)IBA
01/2019 - 01/2016
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 12/2010
3DNA (Deoxyribonucleic Acid)IBA
02/2018 - 12/2003
3Glucagon-Like Peptide-1 ReceptorIBA
12/2017 - 03/2015
3Contrast MediaIBA
01/2017 - 01/2014
3MimosineIBA
01/2016 - 01/2012
3locked nucleic acidIBA
01/2016 - 12/2012
3XenonIBA
07/2015 - 01/2013
3Fibrinogen (Factor I)FDA Link
12/2005 - 12/2003
2ferric pyrophosphateIBA
09/2022 - 06/2022
2Citric Acid (Citrate)FDA LinkGeneric
09/2022 - 06/2022
2Caspase 3 (Caspase-3)IBA
08/2022 - 11/2016
2B7-H1 AntigenIBA
01/2022 - 01/2016
2Apolipoproteins E (ApoE)IBA
01/2022 - 01/2022
2Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2021

Therapy/Procedure

30Therapeutics
01/2022 - 12/2011
9Drug Therapy (Chemotherapy)
04/2022 - 08/2018
8Neoadjuvant Therapy
01/2022 - 01/2020
7Immunotherapy
03/2022 - 01/2020
7Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021 - 04/2012
6Renal Replacement Therapy (Therapies, Renal Replacement)
01/2016 - 01/2010
5Renal Dialysis (Hemodialysis)
09/2022 - 01/2011
4Catheters
03/2021 - 11/2016
4Intraperitoneal Injections
01/2021 - 07/2015
4Stents
12/2017 - 08/2015
3Radiotherapy
04/2022 - 01/2021
3Segmental Mastectomy (Lumpectomy)
01/2022 - 07/2020
3Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2016 - 12/2012